Annual Interest Coverage Ratio
19.57
+3.88+24.73%
31 December 2023
Summary:
Halozyme Therapeutics annual interest coverage ratio is currently 19.57, with the most recent change of +3.88 (+24.73%) on 31 December 2023. During the last 3 years, it has risen by +12.22 (+166.26%). HALO annual interest coverage ratio is now -42.48% below its all-time high of 34.02, reached on 31 December 2021.HALO Interest Coverage Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Coverage Ratio
37.50
+10.47+38.73%
30 September 2024
Summary:
Halozyme Therapeutics quarterly interest coverage ratio is currently 37.50, with the most recent change of +10.47 (+38.73%) on 30 September 2024. Over the past year, it has increased by +13.91 (+58.97%). HALO quarterly interest coverage ratio is now -29.56% below its all-time high of 53.24, reached on 30 June 2021.HALO Quarterly Interest Coverage Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HALO Interest Coverage Ratio Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +24.7% | +59.0% |
| 3 y3 years | +166.3% | -13.3% |
| 5 y5 years | +672.2% | +440.0% |
HALO Interest Coverage Ratio High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -42.5% | +166.3% | -13.4% | +251.4% |
| 5 y | 5 years | -42.5% | +475.6% | -29.6% | +440.0% |
| alltime | all time | -42.5% | +179.9% | -29.6% | +228.3% |
Halozyme Therapeutics Interest Coverage Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 37.50(+38.7%) |
| June 2024 | - | 27.03(+21.2%) |
| Mar 2024 | - | 22.31(+9.5%) |
| Dec 2023 | 19.57(+24.7%) | 20.38(-13.6%) |
| Sept 2023 | - | 23.59(+8.6%) |
| June 2023 | - | 21.73(+73.8%) |
| Mar 2023 | - | 12.50(-24.2%) |
| Dec 2022 | 15.69(-53.9%) | 16.49(+52.5%) |
| Sept 2022 | - | 10.81(+1.3%) |
| June 2022 | - | 10.67(-75.4%) |
| Mar 2022 | - | 43.30(+56.5%) |
| Dec 2021 | 34.02(+362.9%) | 27.67(-36.0%) |
| Sept 2021 | - | 43.25(-18.8%) |
| June 2021 | - | 53.24(+248.2%) |
| Mar 2021 | - | 15.29(-1.7%) |
| Dec 2020 | 7.35(-241.1%) | 15.55(+88.0%) |
| Sept 2020 | - | 8.27(+34.0%) |
| June 2020 | - | 6.17(-4507.1%) |
| Mar 2020 | - | -0.14(-98.3%) |
| Dec 2019 | -5.21(+52.3%) | -8.24(-25.3%) |
| Sept 2019 | - | -11.03(+140.3%) |
| June 2019 | - | -4.59(-392.4%) |
| Mar 2019 | - | 1.57(+201.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | -3.42(-190.0%) | 0.52(-109.5%) |
| Sept 2018 | - | -5.50(+45.1%) |
| June 2018 | - | -3.79(-10.0%) |
| Mar 2018 | - | -4.21(-118.1%) |
| Dec 2017 | 3.80(-192.7%) | 23.27(+1354.4%) |
| Sept 2017 | - | 1.60(-135.4%) |
| June 2017 | - | -4.52(-9.6%) |
| Mar 2017 | - | -5.00(+25.9%) |
| Dec 2016 | -4.10(-21.2%) | -3.97(-7.0%) |
| Sept 2016 | - | -4.27(+5.2%) |
| June 2016 | - | -4.06(-1.2%) |
| Mar 2016 | - | -4.11(-195.1%) |
| Dec 2015 | -5.20(-53.8%) | 4.32(-124.3%) |
| Sept 2015 | - | -17.80(-636.1%) |
| June 2015 | - | 3.32(-131.2%) |
| Mar 2015 | - | -10.63(+275.6%) |
| Dec 2014 | -11.25(-54.1%) | -2.83(-79.4%) |
| Sept 2014 | - | -13.74(+34.4%) |
| June 2014 | - | -10.22(-44.1%) |
| Mar 2014 | - | -18.29(-37.4%) |
| Dec 2013 | -24.50 | -29.24(+34.7%) |
| Sept 2013 | - | -21.70(-16.5%) |
| June 2013 | - | -25.99(+19.5%) |
| Mar 2013 | - | -21.75 |
FAQ
- What is Halozyme Therapeutics annual interest coverage ratio?
- What is the all time high annual interest coverage ratio for Halozyme Therapeutics?
- What is Halozyme Therapeutics annual interest coverage ratio year-on-year change?
- What is Halozyme Therapeutics quarterly interest coverage ratio?
- What is the all time high quarterly interest coverage ratio for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly interest coverage ratio year-on-year change?
What is Halozyme Therapeutics annual interest coverage ratio?
The current annual interest coverage ratio of HALO is 19.57
What is the all time high annual interest coverage ratio for Halozyme Therapeutics?
Halozyme Therapeutics all-time high annual interest coverage ratio is 34.02
What is Halozyme Therapeutics annual interest coverage ratio year-on-year change?
Over the past year, HALO annual interest coverage ratio has changed by +3.88 (+24.73%)
What is Halozyme Therapeutics quarterly interest coverage ratio?
The current quarterly interest coverage ratio of HALO is 37.50
What is the all time high quarterly interest coverage ratio for Halozyme Therapeutics?
Halozyme Therapeutics all-time high quarterly interest coverage ratio is 53.24
What is Halozyme Therapeutics quarterly interest coverage ratio year-on-year change?
Over the past year, HALO quarterly interest coverage ratio has changed by +13.91 (+58.97%)